IDO1 and cancer: Indoleamine-2,3-dioxygenase 1 (IDO1), which is a cytosolic enzyme catalyzing the rate-limiting step of tryptophan (Trp) catabolism to kynurenine (Kyn), has been found to be a key factor in defining cancer immunogenicity.